Sugar-based Excipients Market Size to Reach USD 1,542.5 Million in 2028, Noted Reports and Data

Increasing use of co-processed excipients to improve dissolution, solubility, bioavailability of drugs, rising demand of generic oral prescribed medications, and technological advancements in sugar-based excipients are some key factors driving market growth.

The global sugar-based excipient market size is expected to reach USD 1,542.5 Million in 2028 at a CAGR of 4.5%, according to the latest report by Reports and Data. Increasing use of co-processed excipients to improve dissolution, bioavailability, growth in pharmaceuticals manufacturers, surging demand and production of Orally Disintegrated Tablets (ODT), rising demand of pharmaceuticals drugs, scientific development in genetics industry, and availability of low-cost manufacturing infrastructure, and technological advancements in sugar-based excipients are some key factors expected to drive market revenue growth over the forecast period.

Excipients are the inactive substances that are used in production of drugs specifically to conceal the effect or the bitterness of active agents present in drugs. Sugar-based excipients have been FDA-approved substances used in medicines given to children. Sugar-based excipients are most popularly used in antibiotics and cough syrups. They are primarily applicable in disintegration of Active Pharmaceutical Ingredients (API) present in medicines, and widely used in sucrose, glycerol, saccharin sodium, and sorbitol. Sugar-based excipients are also used as fillers, binders and coating materials, they reduces stickiness and enhance flavors of medicines, making it highly palatable.

Increasing government initiatives to support production of sugar-based excipients is one of the key factors expected to boost market revenue growth over the forecast period. There are lucrative opportunities to the market players operating in the global sugar-based excipients market because of rising expansion and development in pharmaceutical companies. Growing development in oral prescription medications, increasing adoption of co-processed excipients, and government support in drug advancement are some key factors expected to contribute to market growth going ahead. However, rising administrative demands lead to shortage of FDA-approved products, high costs of sugar-based excipients, and issues with the quality, and impurities present in sugar-based excipients are expected to hamper market growth to a certain extent over the forecast period.

Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/437

Some Key Highlights from the Report:

• Actual sugar segment is expected to account for a sizeable revenue share in the global market owing to its increased utilization in oral prescription medicines, and pediatric formulation due to its non-toxicity, and high-efficiency.
• Coatings powders/granules segment is expected to register robust revenue CAGR over the forecast period owing to increasing applications in medical & pharmaceutical industries, expansion of generic medicines, and increasing pediatric population.
• Asia Pacific market revenue is expected to expand significantly over the forecast period owing to increasing growth and development in genetics field, growing healthcare and pharmaceutical industry, development in Orally Disintegrating Tablets (ODTs), and increasing government funding and investment in healthcare sector to support growth and innovation in sugar-based excipients.
• Key companies in the market include DFE Pharma, Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation, Associated British Foods PLC, Cargill, Inc., Colorcon Inc., FMC Corporation, and Meggle AG.

Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/437

For the purpose of this report, Reports and Data has segmented the global sugar-based excipients market has been segmented into type, application, and region:

Type Outlook (Revenue, USD Billion; 2018 – 2028)

• Actual Sugars
• Sugar Alcohols
• Artificial Sweeteners

Application Outlook (Revenue, USD Billion; 2018 – 2028)

• Coatings Powders/Granules
• Direct Compression Sugars
• Crystals, Syrups

Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/437

Region Outlook (Revenue, USD Billion; 2018 – 2028)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • BENELUX
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • U.A.E.
  • South Africa
  • Rest of Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Radiation Proctitis Treatment Market Size, Share & Analysis, By Type (Non-Invasive, Invasive), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Therapy (Oral Therapy, Rectal Instillation Therapy, Thermal Therapy, Hyperbaric Oxygen Therapy), Route of Administration (Oral, Intravenous, Intramuscular) and Region, Forecast To 2028 Size, Share & Analysis, By Type (Non-Invasive, Invasive), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Therapy (Oral Therapy, Rectal Instillation Therapy, Thermal Therapy, Hyperbaric Oxygen Therapy), Route of Administration (Oral, Intravenous, Intramuscular) and Region, Forecast To 2028

Cancer Pain Market Size, Share & Analysis, By Drug Type (Opioids, Non-steroidal Anti-inflammatory Drugs), By Route of Administration (Parenteral, Oral), By Application (Lung Cancer, Colorectal Cancer, Breast Cancer, Blood Cancer, Prostate Cancer), By End-Use (Hospitals, Specialty Clinics, Homecare), And By Region Forecasts To 2028

Levofloxacin Tablets Market Size, Share & Analysis, By Product Type (250 mg Tablets, 500 mg Tablets, 750 mg Tablets), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Pneumonia, Skin Infection, Kidney Infection, Bladder Infection, Others), And By Region, Forecast To 2028

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Read Full Press Release: https://www.reportsanddata.com/press-release/global-sugar-based-excipients-market